Search research articles
Contact Us
Filters
Showing results (71-80 of 162) with videos related to
Page
of 17
Sort By:
Blood
|
September 1, 2005
Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia
Bipin N Savani, Katayoun Rezvani, Stephan Mielke, et al.
Blood
|
May 17, 2007
Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia
Katayoun Rezvani, Agnes S M Yong, Bipin N Savani, et al.
Blood
|
December 7, 2006
Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia
Phillip Scheinberg, Steven H Fischer, Li Li, et al.
Blood
|
August 2, 2003
Clonal dominance of chronic myelogenous leukemia is associated with diminished sensitivity to the antiproliferative effects of neutrophil elastase
Frank El-Ouriaghli, Elaine Sloand, Lori Mainwaring, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2006
T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome
Aldemar Montero, Bipin N Savani, Aarthi Shenoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2016
Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
Hiroki Tanaka, Hiroshi Fujiwara, Fumihiro Ochi, et al.
Transfusion
|
June 28, 2017
Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor-mutated essential thrombocythemia
Celina Montemayor-Garcia, Rebecca Coward, Maher Albitar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2005
T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization
Katayoun Rezvani, Jason M Brenchley, David A Price, et al.
Cytotherapy
|
April 12, 2017
Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy
Prathima Anandi, Xin Tian, Sawa Ito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2007
Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation
Bipin N Savani, Stephan Mielke, Katayoun Rezvani, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 162) with videos related to
Sort By:
Page
of 17
Blood
|
September 1, 2005
Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia
Bipin N Savani, Katayoun Rezvani, Stephan Mielke, et al.
Blood
|
May 17, 2007
Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia
Katayoun Rezvani, Agnes S M Yong, Bipin N Savani, et al.
Blood
|
December 7, 2006
Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia
Phillip Scheinberg, Steven H Fischer, Li Li, et al.
Blood
|
August 2, 2003
Clonal dominance of chronic myelogenous leukemia is associated with diminished sensitivity to the antiproliferative effects of neutrophil elastase
Frank El-Ouriaghli, Elaine Sloand, Lori Mainwaring, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2006
T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome
Aldemar Montero, Bipin N Savani, Aarthi Shenoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2016
Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
Hiroki Tanaka, Hiroshi Fujiwara, Fumihiro Ochi, et al.
Transfusion
|
June 28, 2017
Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor-mutated essential thrombocythemia
Celina Montemayor-Garcia, Rebecca Coward, Maher Albitar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2005
T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization
Katayoun Rezvani, Jason M Brenchley, David A Price, et al.
Cytotherapy
|
April 12, 2017
Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy
Prathima Anandi, Xin Tian, Sawa Ito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2007
Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation
Bipin N Savani, Stephan Mielke, Katayoun Rezvani, et al.
Page
of 17